Le Lézard
Classified in: Health
Subjects: RCL, PSF

Food Recall Warning (Allergen) - Northern King brand and Thai Gold brand Shrimp Tempura recalled due to undeclared egg, soy, milk, and sulphites


Product photos are available at: https://inspection.canada.ca/eng/1635537125574/1635537131395

OTTAWA, ON, Oct. 29, 2021 /CNW/ - TFI Foods Ltd. is recalling Northern King brand and Thai Gold brand Shrimp Tempura from the marketplace because they contain egg and may contain soy, milk, and sulphites which are not declared on the label. People with an allergy to egg, soy, or milk or a sensitivity to sulphites should not consume the recalled products described below.

The following products have been sold nationally.

Recalled products

Brand

Product

Size

UPC

Code

Northern King

Shrimp Tempura
26/30 ct/lb

600 g

0 61391 24216 5

All codes where egg, soy, milk, and sulphites are not declared on the label

Northern King

Shrimp Tempura
31/40 ct/lb

600 g

0 61391 12103 3

All codes where egg, soy, milk, and sulphites are not declared on the label

Northern King

Shrimp Tempura
31/40 ct/lb

500 g

0 61391 24242 4

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-on) 16/20 pieces/lb

1.135 kg

0 61391 22921 0

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-off) 16/20 pieces/lb

1.135 kg

0 61391 22923 4

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-on) 21/25 pieces/lb

1.135 kg

0 61391 24280 6

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-on) 26/30 pieces/lb

1.135 kg

0 61391 24281 3

All codes where egg, soy, milk, and sulphites are not declared on the label

What you should do

Check to see if you have the recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to egg, soy, or milk or a sensitivity to sulphites, do not consume the recalled products as they may cause a serious or life-threatening reaction.

Background

This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of these products.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 08:30
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device...

at 08:15
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced that results from the pivotal Phase 2 TRUST-I study conducted in China evaluating taletrectinib, its...

at 08:05
Takeda (TSE:4502/NYSE:TAK) and Pfizer today announced that the German Hodgkin Study Group (GHSG) will present positive results from the Phase 3 HD21 trial evaluating ADCETRIS® (brentuximab vedotin) in combination with chemotherapy as a late-breaking...

at 08:05
Summit Therapeutics Inc. ("Summit," "we," or the "Company") announced that the Journal of the American Medical Association (JAMA) published a manuscript titled, "Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer with EGFR Variant: A...

at 08:05
Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced data from an ongoing Phase 1 study of AC699 monotherapy in patients with ER-positive / HER2-negative locally advanced or...

at 08:05
Gilead Sciences, Inc. and Arcus Biosciences, Inc. today announced longer-term efficacy and safety results from Arm A1 of the Phase 2 EDGE-Gastric study. These updated data show consistent objective response rate (ORR) and provide mature...



News published on and distributed by: